Skip to main content
PBLS logo

Parabilis Medicines, Inc.

PBLSNASDAQHealthcareBiotechnology

$25.03Today:- (-)

As of Oct 26, 2026 close

Market cap
$723.57M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$22.66$42.49
Volume (live)
-
Avg. volume (3M)
1.35M

Parabilis Medicines (PBLS) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), Parabilis Medicines reported total assets of $80.82M and total liabilities of $97.34M. Shareholders' equity was negative at −$16.52M, meaning liabilities exceed assets. Total debt stood at $58.70M against $27.71M in cash and short-term investments, a net debt position of $30.99M.

Parabilis Medicines Balance Sheet Analysis

Values in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Parabilis Medicines, Inc. (PBLS) - Annual data in millions USD
BreakdownFY 2025FY 2024
Period endingDec 2025Dec 2024
Current Assets
Cash and Cash Equivalents27.7147.28
Short-Term Investments0.0040.69
Cash & Short-Term Investments27.7187.98
Accounts Receivable0.000.36
Inventory0.000.00
Other Current Assets1.653.87
Total Current Assets29.3692.21
Non-Current Assets
Property, Plant & Equipment (Net)46.0852.93
Other Non-Current Assets5.394.12
Total Non-Current Assets51.4657.05
Total Assets80.82149.25
Current Liabilities
Accounts Payable17.279.51
Short-Term Debt20.899.38
Current Portion of Long-Term Debt13.082.50
Accrued Liabilities18.6313.52
Other Current Liabilities18.6313.52
Total Current Liabilities56.7932.41
Non-Current Liabilities
Long-Term Debt37.8112.79
Other Non-Current Liabilities2.743.58
Total Non-Current Liabilities40.5560.40
Total Liabilities97.3492.81
Stockholders' Equity
Retained Earnings-541.50-395.62
Accumulated Other Comprehensive Income0.000.02
Additional Paid-in Capital15.0111.66
Shares Outstanding118.15118.15
Total Stockholders' Equity-16.5256.44
Total Liabilities & Equity80.82149.25

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Parabilis Medicines Balance Sheet

How much debt does Parabilis Medicines have?

Parabilis Medicines had total debt of $58.70M as of Dec 31, 2025, against $27.71M in cash and short-term investments. Total debt was $22.16M a year earlier.

What are Parabilis Medicines's total assets?

Parabilis Medicines reported total assets of $80.82M as of Dec 31, 2025, down 45.9% from $149.25M a year earlier. Total liabilities were $97.34M.

What is Parabilis Medicines's shareholders' equity?

Parabilis Medicines's shareholders' equity was negative at −$16.52M as of Dec 31, 2025, so its liabilities exceeded its assets.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition